Extract
Each year, approximately 1.5 million musculoskeletal allografts are
distributed for
transplantation1.
Allograft tissues offer advantages over autografts, such as smaller surgical
incisions, reduced operative times, and lack of donor-site
morbidity2. A
disadvantage of allografts is the potential, albeit low, for disease
transmission. Recent investigations have implicated a variety of allografts in
the transmission of several
microorganisms3-7.
We investigated the occurrence of invasive group-A streptococcal disease in a
musculoskeletal allograft recipient.